Guilin Sanjin Pharmaceutical Co., Ltd. Stock: price and insider trades · China
桂林三金
No insider purchase over the last 90 days. The latest, by 邹洵, was filed 26 Apr 2024.
Guilin Sanjin Pharmaceutical Co., Ltd.: what insiders have been doing
We have very little insider data for Guilin Sanjin Pharmaceutical Co., Ltd. so far: the most recent filing dates from 26 April 2024. With so few records, no pattern can be drawn yet. These figures are compiled from regulatory filings published by SSE / SZSE (CSRC). They describe what insiders did and are not a recommendation.
Since the insiders bought
- -3.5%Entry CN¥14.17 · Close at T+365 CN¥13.67
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
- 148,300 shares100.0% of flowA股XSHESZSE:173000007573328670Canonical exit: 25 Jul 2024 (T+90)
1 of 1 declaration
About Guilin Sanjin Pharmaceutical Co., Ltd.
桂林三金 is a company in the health and pharmaceutical sector, known for its traditional Chinese pharmaceutical products. It is listed on the XSHE market.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
